Jasper Therapeutics, a biotech looking to make stem cell transplants less taxing and to treat immune-mediated diseases, ...

Research provides evidence that a drug used to slow the progression of the disease ALS shows promise in suppressing the self-renewing cancerous stem cells that challenge the present standards of care ...

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer ...

A combination of two drugs that can block the growth of cancer cells has shown promising results in women with a form of ...

Based on research and analysis of the global Pluripotent stem cell drug market, as well as studies and evaluations of relevant companies in the industry, Frost & Sullivan has granted ZEPHYRM ...

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy ...

Researchers from Osaka University have revealed a close link between polyploidy and DNA damage, showing that the presence of ...

In a perspective article published in Science, Professor Jonathan Rivnay explores next-generation bioelectronic medication.

Gilead Sciences said on Friday it was voluntarily withdrawing the U.S. approval for Trodelvy in previously treated patients ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

Researchers are investigating whether drugs currently used for diabetes and eye diseases could help to prevent or treat ...